SciELO - Scientific Electronic Library Online

 
vol.131 número9Menores quemados por el sol y su relación con la radiación ultravioleta y la cubierta de ozono, durante seis veranos (1996 a 2001) en Santiago de Chile (33,5°S)Diagnóstico de ingreso y evolución nutricional de los beneficiarios de la Corporación para la Nutrición Infantil (CONIN) índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

PUGA L, Bárbara et al. High risk febrile neutropenia in acute leukemia: The experience of a public hospital. Rev. méd. Chile [online]. 2003, vol.131, n.9, pp.1023-1030. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872003000900008.

Febrile neutropenia is one of the most important problems to face during the treatment of acute leukemia. Aim: To assess the results of a standardized protocol for the treatment of febrile neutropenia and compare it with a period in which treatment was not standardized. Patients and methods: One hundred and eight episodes of febrile neutropenia in 69 patients, treated with a standardized antimicrobial protocol between 1996 and 2001, were analyzed. The protocol consisted in the use of a combination of antimicrobial whose spectrum was broadened progressively according to the isolated microorganisms and the involved foci. These were compared with 83 episodes in 54 patients, treated without standardized protocols between 1990 and 1995. Results: Both groups of patients were comparable. Their ages ranged from 15 to 65 years old. The male/female ratio was 1.3 and the lymphoblastic/myeloid leukemia ratio was 1.4. Sixty one percent of episodes occurred during induction chemotherapy and mean duration of neutropenia was 17 days. A clinically significant focus was identified in 72% of episodes and a microorganism was isolated blood culture in 35% of them. There was a predominance of gram negative organisms. The mortality decreased from 18 to 9% in the period 1996-2000 (p=0.094). Conclusions: The use of a standardized antimicrobial protocol reduced the mortality in febrile neutropenia, even when colony stimulating factors and filtered air rooms are unavailable

Palavras-chave : Chemotherapy; adjuvant; Drug therapy; Leukemia; Neutropenia.

        · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons